Jefferies Group's IBB Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 450,807 shares of iShares Biotechnology ETF (IBB) worth $65.08 M, representing 0.31% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in IBB, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 447,001 shares. Largest reduction occurred in Q1 2023, reducing 135,000 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's iShares Biotechnology ETF (IBB) Holding Value Over Time
Track share changes against reported price movement
Quarterly iShares Biotechnology ETF (IBB) Trades by Jefferies Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +135,513 | New Buy | 135,513 | $131.29 |
| Q1 2023 | -135,000 | Reduce 99.62% | 513 | $129.16 |
| Q4 2023 | +347 | Add 67.64% | 860 | $135.90 |
| Q1 2024 | +21,616 | Add 2513.49% | 22,476 | $137.22 |
| Q2 2024 | -18,115 | Reduce 80.60% | 4,361 | $137.25 |
| Q3 2024 | -900 | Reduce 20.64% | 3,461 | $145.61 |
| Q4 2024 | +345 | Add 9.97% | 3,806 | $132.22 |
| Q1 2025 | -3,806 | Sold Out | 3,806 | $0.00 |
| Q3 2025 | +450,807 | New Buy | 450,807 | $144.37 |
Jefferies Group's iShares Biotechnology ETF Investment FAQs
Jefferies Group first purchased iShares Biotechnology ETF (IBB) in Q4 2022, acquiring 135,513 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held iShares Biotechnology ETF (IBB) for 12 quarters since Q4 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's largest addition to iShares Biotechnology ETF (IBB) was in Q3 2025, adding 450,807 shares worth $65.08 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 450,807 shares of iShares Biotechnology ETF (IBB), valued at approximately $65.08 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, iShares Biotechnology ETF (IBB) represents approximately 0.31% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's peak holding in iShares Biotechnology ETF (IBB) was 450,807 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.